<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251022067726N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-11-12</date_registration>
      <primary_sponsor>Zahedan University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Progressive Muscle Relaxation on Fatigue, Functional Ability, and Health Anxiety in Patients after Ischemic Stroke</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Progressive Muscle Relaxation on Fatigue, Functional Ability, and Health Anxiety in Hospitalized Patients after Ischemic Stroke</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-11-29</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/87080</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: In this study, patients diagnosed with ischemic stroke who meet the inclusion criteria will be selected using a convenience sampling method upon admission to the ward. After obtaining written informed consent, each eligible patient will be enrolled as a participant in the study.
The allocation of patients into the intervention and control groups will be performed randomly and immediately after admission. To achieve this, a number of sealed envelopes containing pre-assigned numbers will be placed in a bag, and one of the ward staff members will randomly draw an envelope for each patient. Based on the assigned number, patients with even numbers will be allocated to the control group (receiving routine care), while those with odd numbers will be allocated to the intervention group (receiving progressive muscle relaxation training).
The randomization process will be conducted at the time of hospitalization and prior to the initiation of any intervention to prevent allocation bias and ensure baseline balance between the study groups, Blinding description: In this study, the functional ability of patients in both the intervention and control groups will be assessed on the first day of hospitalization, on the fifth day of hospitalization at the time of discharge, and again four weeks after discharge. Functional status will be measured using the Barthel Index through direct observation or patient interview (and when communication difficulties are present, through an informed caregiver). All assessments will be conducted by an independent evaluator, selected from among master's-level nursing students, who will be blinded to the study details (Blinded Assessor) in order to minimize bias in data collection.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Ischemic Stroke.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention group will undergo progressive muscle relaxation (PMR) training conducted by a trained researcher for five consecutive days. The training sessions will be delivered individually, face-to-face, once daily during the morning shift, and will last approximately 20–30 minutes at the patient’s bedside in the neurology ward. Each session involves the sequential tensing and relaxing of different muscle groups. Patients will be positioned supine, and the exercises will be performed in the following order:1. Raise the eyebrows.2. Close the eyes tightly.3. Clench the jaw and pull the corners of the mouth backward.4. Bring the chin toward the chest (without contact).5. Make a fist with the dominant hand.6. Press the dominant elbow against the body.7. Make a fist with the non-dominant hand.8. Press the non-dominant elbow against the body.9. Pull the shoulders backward, take a deep breath, and hold it.10. Contract the abdomen.11. Lift the dominant leg slightly off the bed and hold.12. Point the toes of the dominant foot upward.13. Flex the toes of the dominant foot toward the sole and then release.14. Lift the non-dominant leg slightly off the bed and hold.15. Point the toes of the non-dominant foot upward.16. Flex the toes of the non-dominant foot toward the sole and then release.Each muscle group will be tensed for 10 seconds and then relaxed for 20–30 seconds . This cycle will be repeated twice for each muscle during every session. Prior to conducting the intervention, the researcher received both theoretical and practical training in progressive muscle relaxation (PMR) under the supervision of a specialist in physical medicine and lifestyle modification and holds a certification in the technique. The exercises will be conducted by the trained researcher following a standardized checklist , and all sessions will be documented in a session log, including start and end times, patient cooperation, and any adverse events or complications such as dizziness, muscle pain, or others. Any serious adverse event attributable to the study will be reported promptly to the Ethics Committee and other relevant legal authorities. Intervention 2: Control group: will receive only routine ward care  and no additional interventions.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Considering that the process of sample collection has not yet begun and data analysis has not been conducted , it is not currently possible to make a  definitive decision regarding the dissemination plan .</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mehdi Rezvaniamin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Mashahir Square, End of Behdasht Blvd</address>
        <city>Zahdan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1339698169</zip>
        <telephone>+98 54 3341 9085</telephone>
        <email>mehdi.rezvaniamin@gmail.com</email>
        <affiliation>Zahedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mehdi Rezvani Amin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery , Mashahir Square, End of Behdasht Blvd</address>
        <city>Zahdan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1339698169</zip>
        <telephone>+98 54 3341 9085</telephone>
        <email>mehdi.rezvaniamin@gmail.com</email>
        <affiliation>Zahedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with confirmed diagnosis of ischemic stroke</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>First occurrence of ischemic stroke
Age range between 20 and 80 years
NIHSS score &lt; 12
Ability to read and write
No history of central nervous system disorders
No history of psychiatric disorders
Accessibility and availability of the patient throughout the study period</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I63</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cerebral infarction</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention group will undergo progressive muscle relaxation (PMR) training conducted by a trained researcher for five consecutive days. The training sessions will be delivered individually, face-to-face, once daily during the morning shift, and will last approximately 20–30 minutes at the patient’s bedside in the neurology ward. Each session involves the sequential tensing and relaxing of different muscle groups. Patients will be positioned supine, and the exercises will be performed in the following order:1. Raise the eyebrows.2. Close the eyes tightly.3. Clench the jaw and pull the corners of the mouth backward.4. Bring the chin toward the chest (without contact).5. Make a fist with the dominant hand.6. Press the dominant elbow against the body.7. Make a fist with the non-dominant hand.8. Press the non-dominant elbow against the body.9. Pull the shoulders backward, take a deep breath, and hold it.10. Contract the abdomen.11. Lift the dominant leg slightly off the bed and hold.12. Point the toes of the dominant foot upward.13. Flex the toes of the dominant foot toward the sole and then release.14. Lift the non-dominant leg slightly off the bed and hold.15. Point the toes of the non-dominant foot upward.16. Flex the toes of the non-dominant foot toward the sole and then release.Each muscle group will be tensed for 10 seconds and then relaxed for 20–30 seconds . This cycle will be repeated twice for each muscle during every session. Prior to conducting the intervention, the researcher received both theoretical and practical training in progressive muscle relaxation (PMR) under the supervision of a specialist in physical medicine and lifestyle modification and holds a certification in the technique. The exercises will be conducted by the trained researcher following a standardized checklist , and all sessions will be documented in a session log, including start and end times, patient cooperation, and any adverse events or complications such as dizziness, muscle pain, or others. Any serious adverse event attributable to the study will be reported promptly to the Ethics Committee and other relevant legal authorities.</i_keyword>
      <i_keyword>Control group: will receive only routine ward care  and no additional interventions.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Fatigue. Timepoint: Fatigue will be measured at baseline (prior to the initiation of the intervention), as well as on days 5 and 33 following the progressive muscle relaxation intervention. Method of measurement: Fatigue Impact Scale.</prim_outcome>
      <prim_outcome>Functional Ability. Timepoint: Functional Ability will be measured at baseline (prior to the initiation of the intervention), as well as on days 5 and 33 following the progressive muscle relaxation intervention. Method of measurement: Barthel and Stroke Impact Scale.</prim_outcome>
      <prim_outcome>Health Anxiety. Timepoint: Health Anxiety  will be measured at baseline (prior to the initiation of the intervention), as well as on days 5 and 33 following the progressive muscle relaxation intervention. Method of measurement: Short Health Anxiety Inventory.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zahedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-10-21</approval_date>
        <contact_name>Ethic committee of Zahedan University of Medical sciences</contact_name>
        <contact_address>Zahedan University of Medical Sciences, Kaj Blvd., Emam Hossein Blvd zahdan Sistan-va-Balouchestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
